Merck KGaA (OTCPK:MKGAF) Q3 2024 Earnings Conference Call November 14, 2024 8:00 AM ET
Company Participants
Constantin Fest - Head of Investor Relations
Belen Lopez - Chair of Executive Board & CEO
Helene von Roeder - CFO
Peter Guenter - CEO of Healthcare Business
Matthias Heinzel - CEO of Life Science Sector
Kai Beckmann - CEO of Electronics
Conference Call Participants
Sachin Jain - Bank of America
Jo Walton - UBS
Sophia Grace - JPMorgan
James Quigley - Goldman Sachs
Charles Pitman-King - Barclays
Thibault Boutherin - Morgan Stanley
Falko Friedrichs - Deutsche Bank
Dylan Van Haaften - Stifel
Oliver Metzger - Oddo BHF
Rajesh Kumar - HSBC
Operator
Dear ladies and gentlemen, welcome to the Merck Investor and Analyst Conference Call on the Third Quarter 2024. As a reminder, all participants will be in a listen-only mode. I am now handing over to Constantin Fest, Head of Investor Relations, who will lead you through the conference. Please go ahead sir.
Constantin Fest
Thank you very much Heidi. A very warm welcome to this Merck Q3 2024 Results Call. My name is Constantin Fest, I'm Head of Investor Relations here at Merck. Today I'm delighted to be joined by Belen Garijo, Group CEO; as well as Helene von Roeder, Group CFO. For the Q&A part of this call, Matthias Heinzel, and Sebastián Arana, Head of Process Solutions was in Germany and quick join on short notice. We are delighted to have them with us covering Process Solutions questions.
Science and Lab Solutions and Life Science Services will be covered by Belen and Helene. Also, joining for the Q&A of this call, we have Peter Guenter, the CEO of Healthcare, as well as Kai Beckmann, CEO of Electronics. We would now like to guide you through the key slides of this presentation, and after that, we'll be happy to take
- Read more current MKGAF analysis and news
- View all earnings call transcripts